首页> 外文期刊>Pediatric neurology >Midazolam fails to prevent neurological damage in children with convulsive refractory febrile status epilepticus
【24h】

Midazolam fails to prevent neurological damage in children with convulsive refractory febrile status epilepticus

机译:咪达唑仑不能预防癫痫性难治性高热状态癫痫患儿的神经系统损害

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: We conducted a retrospective study to compare the outcome of intravenous midazolam infusion without electroencephalography or targeted temperature management and barbiturate coma therapy with electroencephalography and targeted temperature management for treating convulsive refractory febrile status epilepticus. PATIENTS: Of 49 consecutive convulsive refractory febrile status epilepticus patients admitted to the pediatric intensive care unit of our hospital, 29 were excluded because they received other treatments or because of various underlying illnesses. Thus, eight patients were treated with midazolam and 10 with barbiturate coma therapy using thiamylal. Midazolam-treated patients were intubated only when necessary, whereas barbiturate coma therapy patients were routinely intubated. Continuous electroencephalography monitoring was utilized only for the barbiturate coma group. The titration goal for anesthesia was clinical termination of status epilepticus in the midazolam group and suppression or burst-suppression patterns on electroencephalography in the barbiturate coma group. Normothermia was maintained using blankets and neuromuscular blockade in the barbiturate coma group and using antipyretics in the midazolam group. Prognoses were measured at 1 month after onset; children were classified into poor and good outcome groups. RESULTS: Good outcome was achieved in all the barbiturate coma group patients and 50% of the midazolam group patients (P = 0.02, Fisher's exact test). CONCLUSIONS: Although the sample size was small and our study could not determine which protocol element is essential for the neurological outcome, the findings suggest that clinical seizure control using midazolam without continuous electroencephalography monitoring or targeted temperature management is insufficient in preventing neurological damage in children with convulsive refractory febrile status epilepticus.
机译:背景:我们进行了一项回顾性研究,以比较未进行脑电图或目标温度管理的咪达唑仑静脉输注的结果,以及使用脑电图和目标温度管理的巴比妥酸盐昏迷疗法与脑电图和目标温度管理治疗惊厥性难治性高热状态癫痫的比较。患者:在我院儿科重症监护病房连续收治的49例连续性惊厥性难治性发热性癫痫患者中,有29例被排除在外,因为他们接受了其他治疗或各种潜在疾病。因此,有8例患者接受了咪达唑仑治疗,10例接受了使用噻吗洛尔的巴比妥酸盐昏迷治疗。咪达唑仑治疗的患者仅在必要时插管,而巴比妥酸盐昏迷治疗患者则常规插管。连续脑电图监测仅用于巴比妥酸盐昏迷组。麻醉的滴定目标是咪达唑仑组的癫痫持续状态的临床终止和巴比妥酸盐昏迷组在脑电图上的抑制或猝发抑制方式。巴比妥类昏迷组使用毯子和神经肌肉阻滞维持维持正常体温,咪达唑仑组使用退烧药维持常温。在发病后1个月测量预后;将儿童分为不良和良好结局组。结果:所有巴比妥酸盐昏迷组患者和咪达唑仑组患者的50%均取得了良好的预后(P = 0.02,Fisher精确检验)。结论:尽管样本量很小,并且我们的研究无法确定哪个协议元素对于神经系统结局至关重要,但研究结果表明,使用咪达唑仑进行临床癫痫发作控制而不进行连续脑电图监测或有针对性的温度管理不足以预防患有癫痫的儿童的神经系统损害惊厥性难治性发热性癫痫持续状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号